Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker

By F. Solca, G. Dahl, A. Zoephel, G. Bader, M. Sanderson, C. Klein, O. Kraemer, F. Himmelsbach, E. Haaksma, G. Adolf. Journal of Pharmacology and Experimental Therapeutics, 2012

844 citations recorded by the source corpus.

Subfields: Genetics, Oncology, Organic Chemistry

View Paper: https://www.semanticscholar.org/paper/d5672afc6c6ad69058a836250c109038013817d2